Schmitt C, Gross D, SHARE N
Graefes Arch Clin Exp Ophthalmol. 1984; 221(4):167-70.
PMID: 6142847
DOI: 10.1007/BF02134259.
Berdeaux A, Giudicelli J
Br J Clin Pharmacol. 1982; 13(Suppl 2):175S-180S.
PMID: 6125167
PMC: 1402155.
DOI: 10.1111/j.1365-2125.1982.tb01907.x.
Kaumann A, BLINKS J
Naunyn Schmiedebergs Arch Pharmacol. 1980; 311(3):237-48.
PMID: 6104793
DOI: 10.1007/BF00569403.
Kaumann A, BLINKS J
Naunyn Schmiedebergs Arch Pharmacol. 1980; 311(3):205-18.
PMID: 6104791
DOI: 10.1007/BF00569401.
Alexandre J, Chevillard C
Br J Pharmacol. 1980; 69(1):35-40.
PMID: 6103727
PMC: 2044186.
DOI: 10.1111/j.1476-5381.1980.tb10880.x.
Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.
EKELUND L, Melcher A, Oro L
Eur J Clin Pharmacol. 1971; 3(4):198-203.
PMID: 5151303
DOI: 10.1007/BF00565006.
Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.
Vedin J, Wilhelmsson C, WERKO L
Br Heart J. 1973; 35(12):1285-92.
PMID: 4586374
PMC: 458796.
DOI: 10.1136/hrt.35.12.1285.
Effect of -adrenoceptor blocking agents on poststimulatory atrial flutter in the dog, with observations on the participation of adrenergic mechanisms in this experimental arrhythmia.
MADAN B, Soni R
Br J Pharmacol. 1972; 44(1):109-16.
PMID: 4401305
PMC: 1665701.
DOI: 10.1111/j.1476-5381.1972.tb07243.x.
Alprenolol in resuscitation.
PONTINEN J, Eggert H, Kemila S
Br Med J. 1971; 4(5789):723.
PMID: 4399701
PMC: 1799978.
DOI: 10.1136/bmj.4.5789.723.
Reflex and other vascular changes in anaesthetized dogs after beta-adrenoceptor antagonism with alprenolol, bunolol and propranolol.
ROBSON R
Br J Pharmacol. 1970; 40(3):539P-540P.
PMID: 4395747
PMC: 1703155.
Comparative chronotropic activity of beta-adrenoceptive antagonists.
Barrett A, Carter J
Br J Pharmacol. 1970; 40(3):373-81.
PMID: 4395742
PMC: 1703170.
DOI: 10.1111/j.1476-5381.1970.tb10619.x.
Alprenolol and propranolol in hyperthyroid tachycardia.
Turner P
Br J Pharmacol. 1970; 40(1):146P-147P.
PMID: 4395079
PMC: 1702707.
[Modification of sympathetic hyperactivity by drugs. Short-term pharmacologic experiments using parasympathomimetics and beta-receptor blockaders in humans].
von Eiff A, Czernik A, Zanders K
Klin Wochenschr. 1969; 47(13):701-8.
PMID: 4392685
DOI: 10.1007/BF01881620.
Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle.
Singh B, Williams E
Br J Pharmacol. 1970; 38(4):749-57.
PMID: 4392560
PMC: 1702589.
DOI: 10.1111/j.1476-5381.1970.tb09884.x.
Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle.
Bowman W, Nott M
Br J Pharmacol. 1970; 38(1):37-49.
PMID: 4391735
PMC: 1702637.
DOI: 10.1111/j.1476-5381.1970.tb10334.x.
Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats.
Parratt J, Wadsworth R
Br J Pharmacol. 1969; 37(2):357-66.
PMID: 4390668
PMC: 1703687.
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Singh B, Jewitt D
Drugs. 1974; 7(6):426-61.
PMID: 4153572
DOI: 10.2165/00003495-197407060-00004.
Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris.
Adolfsson L, ARESKOG N, Furberg C, Johnsson G
Eur J Clin Pharmacol. 1974; 7(2):111-8.
PMID: 4152864
DOI: 10.1007/BF00561324.
Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Gibson D
Drugs. 1974; 7(1):8-38.
PMID: 4151693
DOI: 10.2165/00003495-197407010-00002.
The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.
Fitzgerald J
Cardiovasc Drugs Ther. 1991; 5(3):561-76.
PMID: 1678960
DOI: 10.1007/BF03029726.
